Bank of America’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-83,826
| Closed | -$87K | – | 7690 |
|
|
2019
Q1 | $87K | Hold |
83,826
| – | – | ﹤0.01% | 5953 |
|
|
2018
Q4 | $63K | Hold |
83,826
| – | – | ﹤0.01% | 6125 |
|
|
2018
Q3 | $178K | Sell |
83,826
-1,403
| -2% | -$3.36K | ﹤0.01% | 5547 |
|
|
2018
Q2 | $197K | Sell |
85,229
-61,649
| -42% | -$180K | ﹤0.01% | 5422 |
|
|
2018
Q1 | $467K | Sell |
146,878
-6,318
| -4% | -$17.4K | ﹤0.01% | 4862 |
|
|
2017
Q4 | $628K | Buy |
153,196
+311
| +0.2% | +$1.35K | ﹤0.01% | 4791 |
|
|
2017
Q3 | $691K | Sell |
152,885
-5,693
| -4% | -$23.1K | ﹤0.01% | 4762 |
|
|
2017
Q2 | $528K | Buy |
158,578
+1,982
| +1% | +$8.22K | ﹤0.01% | 4860 |
|
|
2017
Q1 | $1.44M | Buy |
156,596
+15,850
| +11% | +$139K | ﹤0.01% | 4154 |
|
|
2016
Q4 | $1.08M | Buy |
140,746
+5,842
| +4% | +$53.7K | ﹤0.01% | 4279 |
|
|
2016
Q3 | $1.54M | Sell |
134,904
-900
| -0.7% | -$10.5K | ﹤0.01% | 3848 |
|
|
2016
Q2 | $1.67M | Buy |
135,804
+2,151
| +2% | +$26.1K | ﹤0.01% | 3778 |
|
|
2016
Q1 | $1.35M | Sell |
133,653
-6,492
| -5% | -$76.2K | ﹤0.01% | 3891 |
|
|
2015
Q4 | $3.16M | Buy |
140,145
+8,305
| +6% | +$170K | ﹤0.01% | 3387 |
|
|
2015
Q3 | $2.19M | Buy |
131,840
+7,767
| +6% | +$156K | ﹤0.01% | 3683 |
|
|
2015
Q2 | $2.79M | Buy |
124,073
+29,856
| +32% | +$736K | ﹤0.01% | 3139 |
|
|
2015
Q1 | $2.43M | Buy |
94,217
+1,091
| +1% | +$27.7K | ﹤0.01% | 3062 |
|
|
2014
Q4 | $2.03M | Sell |
93,126
-175
| -0.2% | -$3.58K | ﹤0.01% | 3367 |
|
|
2014
Q3 | $1.77M | Sell |
93,301
-242
| -0.3% | -$4.86K | ﹤0.01% | 3505 |
|
|
2014
Q2 | $2.18M | Buy |
93,543
+371
| +0.4% | +$9.16K | ﹤0.01% | 3290 |
|
|
2014
Q1 | $3.14M | Buy |
93,172
+88,682
| +1,975% | +$2.99M | ﹤0.01% | 2809 |
|
|
2013
Q4 | $133K | Buy |
+4,490
| New | +$82.3K | ﹤0.01% | 5923 |
|
Bank of America's OMED Position: Q2 2019 in Review
Bank of America sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 83,826 shares — an estimated $87K sold.
Bank of America first reported a position in OMED in Q4 2013 and held it in 22 quarters. The position peaked at $3.16M in Q4 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Bank of America reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Bank of America sold 83,826 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $87K.
- Bank of America first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2013 and held it in 22 quarters.
- Bank of America's OncoMed Pharmaceuticals, Inc. position peaked at $3.16M in Q4 2015.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Bank of America's 13F filing for Q2 2019, filed 14 Aug 2019.